TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs3131382
log Bayes Factor = 53.2108
Chromosome 6   position 31,707,730  (GRCh37) Explore rs3131382 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E10.9 Without complications
0.000 0.000 1.000
E83.1 Disorders of iron metabolism
1.000 0.000 0.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
G35 Multiple sclerosis
1.000 0.000 0.000
E10-E14 Diabetes mellitus
0.000 0.000 1.000
E11.9 Without complications
0.000 0.000 1.000
E10.3 With ophthalmic complications
0.000 0.000 1.000
E11 Non-insulin-dependent diabetes mellitus
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.000 1.000
E78.0 Pure hypercholesterolaemia
0.000 0.000 1.000
I20-I25 Ischaemic heart diseases
0.000 0.000 1.000
I25 Chronic ischaemic heart disease
0.000 0.001 0.999
L40.9 Psoriasis, unspecified
0.000 0.001 0.999
E00-E07 Disorders of thyroid gland
0.000 0.001 0.999
E03.9 Hypothyroidism, unspecified
0.000 0.001 0.999
E03 Other hypothyroidism
0.000 0.001 0.999
G35-G37 Demyelinating diseases of the central nervous system
0.999 0.001 0.000
L40 Psoriasis
0.000 0.002 0.998
J45.9 Asthma, unspecified
0.000 0.003 0.997
L40.5 Arthropathic psoriasis
0.000 0.005 0.995
I10 Essential (primary) hypertension
0.000 0.005 0.995
Chapter VI Diseases of the nervous system
0.991 0.009 0.000
I20 Angina pectoris
0.000 0.012 0.988
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.012 0.987
E70-E90 Metabolic disorders
0.002 0.014 0.984
I22 Subsequent myocardial infarction
0.000 0.019 0.981
I25.1 Atherosclerotic heart disease
0.000 0.021 0.979
I10-I15 Hypertensive diseases
0.000 0.023 0.977
I25.2 Old myocardial infarction
0.000 0.025 0.975
E10.1 With ketoacidosis
0.000 0.026 0.974
E83 Disorders of mineral metabolism
0.967 0.027 0.006
E10.4 With neurological complications
0.000 0.029 0.971
I20.0 Unstable angina
0.000 0.033 0.967
G37 Other demyelinating diseases of central nervous system
0.963 0.037 0.000
L40-L45 Papulosquamous disorders
0.000 0.043 0.957
G30-G32 Other degenerative diseases of the nervous system
0.954 0.046 0.000
E14 Unspecified diabetes mellitus
0.000 0.048 0.952
G00-G09 Inflammatory diseases of the central nervous system
0.946 0.054 0.000
I25.8 Other forms of chronic ischaemic heart disease
0.000 0.055 0.945
I24 Other acute ischaemic heart diseases
0.000 0.063 0.937
I20.9 Angina pectoris, unspecified
0.000 0.064 0.936
G31 Other degenerative diseases of nervous system, not elsewhere classified
0.930 0.070 0.000
E83.5 Disorders of calcium metabolism
0.928 0.071 0.000
G20-G26 Extrapyramidal and movement disorders
0.926 0.074 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.076 0.924
L43 Lichen planus
0.000 0.078 0.922
M06.9 Rheumatoid arthritis, unspecified
0.000 0.087 0.913
I22.9 Subsequent myocardial infarction of unspecified site
0.000 0.091 0.909
G31.9 Degenerative disease of nervous system, unspecified
0.908 0.092 0.000
G37.9 Demyelinating disease of central nervous system, unspecified
0.906 0.094 0.000
G90-G99 Other disorders of the nervous system
0.903 0.097 0.000
Chapter IX Diseases of the circulatory system
0.000 0.097 0.903
I22.1 Subsequent myocardial infarction of inferior wall
0.000 0.098 0.902
G20 Parkinson's disease
0.902 0.098 0.000
E14.3 With ophthalmic complications
0.000 0.099 0.901
I24.9 Acute ischaemic heart disease, unspecified
0.000 0.102 0.898
L43.9 Lichen planus, unspecified
0.000 0.103 0.897
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.113 0.887
M06 Other rheumatoid arthritis
0.000 0.115 0.885
E83.3 Disorders of phosphorus metabolism
0.878 0.120 0.002
I12 Hypertensive renal disease
0.000 0.124 0.876
E16 Other disorders of pancreatic internal secretion
0.000 0.130 0.870
G37.8 Other specified demyelinating diseases of central nervous system
0.868 0.132 0.000
M05-M14 Inflammatory polyarthropathies
0.000 0.139 0.861
E10.2 With renal complications
0.000 0.139 0.861
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.000 0.148 0.852
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.153 0.847
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.000 0.159 0.841
G93 Other disorders of brain
0.839 0.161 0.000
I25.5 Ischaemic cardiomyopathy
0.000 0.162 0.838
E78.2 Mixed hyperlipidaemia
0.000 0.164 0.836
I22.0 Subsequent myocardial infarction of anterior wall
0.000 0.165 0.835
E13 Other specified diabetes mellitus
0.000 0.169 0.831
E16.2 Hypoglycaemia, unspecified
0.000 0.169 0.831
E11.5 With peripheral circulatory complications
0.000 0.171 0.829
G03 Meningitis due to other and unspecified causes
0.821 0.179 0.000
M07 Psoriatic and enteropathic arthropathies
0.000 0.180 0.820
E07 Other disorders of thyroid
0.000 0.185 0.815
E10.5 With peripheral circulatory complications
0.000 0.186 0.814
E11.2 With renal complications
0.000 0.189 0.811
I21 Acute myocardial infarction
0.000 0.190 0.810
I24.0 Coronary thrombosis not resulting in myocardial infarction
0.000 0.193 0.807
E14.9 Without complications
0.000 0.203 0.797
I11 Hypertensive heart disease
0.000 0.208 0.792
M07.3 Other psoriatic arthropathies
0.000 0.209 0.791
G00 Bacterial meningitis, not elsewhere classified
0.790 0.210 0.000
I15 Secondary hypertension
0.000 0.211 0.789
G04 Encephalitis, myelitis and encephalomyelitis
0.784 0.216 0.000
G80-G83 Cerebral palsy and other paralytic syndromes
0.779 0.221 0.000
M05 Seropositive rheumatoid arthritis
0.000 0.224 0.776
E11.6 With other specified complications
0.000 0.226 0.774
I12.0 Hypertensive renal disease with renal failure
0.000 0.227 0.773
E06 Thyroiditis
0.000 0.232 0.768
G09 Sequelae of inflammatory diseases of central nervous system
0.765 0.235 0.000
I20.1 Angina pectoris with documented spasm
0.000 0.240 0.760
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.242 0.758
E11.1 With ketoacidosis
0.000 0.243 0.757
I21.2 Acute transmural myocardial infarction of other sites
0.000 0.244 0.756
J45 Asthma
0.000 0.257 0.743
I25.3 Aneurysm of heart
0.000 0.257 0.743
E78.1 Pure hyperglyceridaemia
0.000 0.259 0.741
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.263 0.737
# Top node
0.000 0.264 0.736
G03.9 Meningitis, unspecified
0.731 0.269 0.000
Chapter XII Diseases of the skin and subcutaneous tissue
0.000 0.271 0.729
G97 Postprocedural disorders of nervous system, not elsewhere classified
0.729 0.271 0.000
G31.2 Degeneration of nervous system due to alcohol
0.728 0.272 0.000
E03.8 Other specified hypothyroidism
0.000 0.272 0.728
M07.30 Other psoriatic arthropathies (Multiple sites)
0.000 0.275 0.725
I25.0 Atherosclerotic cardiovascular disease, so described
0.000 0.275 0.725
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.000 0.276 0.724
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.276 0.724
G91 Hydrocephalus
0.722 0.278 0.000
M07.39 Other psoriatic arthropathies (Site unspecified)
0.000 0.280 0.720
E10.8 With unspecified complications
0.000 0.283 0.717
E10.7 With multiple complications
0.000 0.283 0.717
E10.6 With other specified complications
0.000 0.283 0.717
E10.0 With coma
0.000 0.283 0.717
E12 Malnutrition-related diabetes mellitus
0.000 0.283 0.717
E11.7 With multiple complications
0.000 0.283 0.717
I25.6 Silent myocardial ischaemia
0.000 0.283 0.716
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.284 0.716
E00 Congenital iodine-deficiency syndrome
0.000 0.284 0.716
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.284 0.716
E03.5 Myxoedema coma
0.000 0.284 0.716
E03.4 Atrophy of thyroid (acquired)
0.000 0.284 0.716
E03.3 Postinfectious hypothyroidism
0.000 0.284 0.716
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.284 0.716
E03.1 Congenital hypothyroidism without goitre
0.000 0.284 0.716
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.284 0.716
G36 Other acute disseminated demyelination
0.716 0.284 0.000
L40.8 Other psoriasis
0.000 0.284 0.716
L40.4 Guttate psoriasis
0.000 0.284 0.716
L40.3 Pustulosis palmaris et plantaris
0.000 0.284 0.716
L40.2 Acrodermatitis continua
0.000 0.284 0.716
L40.1 Generalised pustular psoriasis
0.000 0.284 0.716
M05.9 Seropositive rheumatoid arthritis, unspecified
0.000 0.286 0.714
Chapter XIII Diseases of the musculoskeletal system and connective tissue
0.000 0.286 0.714
E78.8 Other disorders of lipoprotein metabolism
0.000 0.286 0.713
I23 Certain current complications following acute myocardial infarction
0.000 0.288 0.712
E13.9 Without complications
0.000 0.291 0.709
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.000 0.291 0.709
G93.3 Postviral fatigue syndrome
0.709 0.291 0.000
E78.6 Lipoprotein deficiency
0.000 0.292 0.708
E78.3 Hyperchylomicronaemia
0.000 0.292 0.708
E11.8 With unspecified complications
0.000 0.292 0.708
E84 Cystic fibrosis
0.002 0.293 0.705
E79 Disorders of purine and pyrimidine metabolism
0.002 0.293 0.705
E77 Disorders of glycoprotein metabolism
0.002 0.293 0.705
E76 Disorders of glycosaminoglycan metabolism
0.002 0.293 0.705
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.002 0.293 0.705
E74 Other disorders of carbohydrate metabolism
0.002 0.293 0.705
E72 Other disorders of amino-acid metabolism
0.002 0.293 0.705
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.002 0.293 0.705
E70 Disorders of aromatic amino-acid metabolism
0.002 0.293 0.705
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.002 0.293 0.705
I12.9 Hypertensive renal disease without renal failure
0.000 0.297 0.703
G10-G14 Systemic atrophies primarily affecting the central nervous system
0.701 0.298 0.000
I13 Hypertensive heart and renal disease
0.000 0.299 0.701
E83.9 Disorder of mineral metabolism, unspecified
0.693 0.302 0.004
E83.8 Other disorders of mineral metabolism
0.693 0.302 0.004
E83.2 Disorders of zinc metabolism
0.693 0.302 0.004
E83.0 Disorders of copper metabolism
0.693 0.302 0.004
M06.0 Seronegative rheumatoid arthritis
0.000 0.304 0.696
G06 Intracranial and intraspinal abscess and granuloma
0.694 0.306 0.000
G37.5 Concentric sclerosis [Balo]
0.690 0.310 0.000
G37.4 Subacute necrotising myelitis
0.690 0.310 0.000
G37.2 Central pontine myelinolysis
0.690 0.310 0.000
G37.1 Central demyelination of corpus callosum
0.690 0.310 0.000
G37.0 Diffuse sclerosis
0.690 0.310 0.000
G01 Meningitis in bacterial diseases classified elsewhere
0.688 0.312 0.000
L44 Other papulosquamous disorders
0.000 0.314 0.686
L41 Parapsoriasis
0.000 0.314 0.686
L45 Papulosquamous disorders in diseases classified elsewhere
0.000 0.314 0.686
L42 Pityriasis rosea
0.000 0.314 0.686
G32 Other degenerative disorders of nervous system in diseases classified elsewhere
0.684 0.316 0.000
E14.8 With unspecified complications
0.000 0.317 0.683
E14.7 With multiple complications
0.000 0.317 0.683
E14.6 With other specified complications
0.000 0.317 0.683
E14.5 With peripheral circulatory complications
0.000 0.317 0.683
E14.2 Withrenal complications
0.000 0.317 0.683
E14.1 With ketoacidosis
0.000 0.317 0.683
E14.0 With coma
0.000 0.317 0.683
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.001 0.318 0.681
G02 Meningitis in other infectious and parasitic diseases classified elsewhere
0.678 0.322 0.000
G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere
0.678 0.322 0.000
I21.0 Acute transmural myocardial infarction of anterior wall
0.000 0.324 0.676
E40-E46 Malnutrition
0.000 0.324 0.676
G83 Other paralytic syndromes
0.675 0.325 0.000
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere
0.674 0.326 0.000
E78.4 Other hyperlipidaemia
0.000 0.326 0.673
G93.4 Encephalopathy, unspecified
0.673 0.327 0.000
G70-G73 Diseases of myoneural junction and muscle
0.673 0.327 0.000
I24.1 Dressler's syndrome
0.000 0.328 0.672
I11.9 Hypertensive heart disease without (congestive) heart failure
0.000 0.329 0.671
E80 Disorders of porphyrin and bilirubin metabolism
0.001 0.331 0.667
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified
0.667 0.333 0.000
M14 Arthropathies in other diseases classified elsewhere
0.000 0.333 0.667
G31.1 Senile degeneration of brain, not elsewhere classified
0.667 0.333 0.000
G31.0 Circumscribed brain atrophy
0.667 0.333 0.000
G94 Other disorders of brain in diseases classified elsewhere
0.667 0.333 0.000
M11 Other crystal arthropathies
0.000 0.335 0.665
G23 Other degenerative diseases of basal ganglia
0.664 0.336 0.000
G21 Secondary Parkinsonism
0.664 0.336 0.000
G26 Extrapyramidal and movement disorders in diseases classified elsewhere
0.664 0.336 0.000
G22 Parkinsonism in diseases classified elsewhere
0.664 0.336 0.000
G96 Other disorders of central nervous system
0.663 0.337 0.000
E15 Nondiabetic hypoglycaemic coma
0.000 0.337 0.663
G98 Other disorders of nervous system, not elsewhere classified
0.663 0.337 0.000
L43.8 Other lichen planus
0.000 0.339 0.661
L43.3 Subacute (active) lichen planus
0.000 0.339 0.661
L43.2 Lichenoid drug reaction
0.000 0.339 0.661
L43.1 Bullous lichen planus
0.000 0.339 0.661
L43.0 Hypertrophic lichen planus
0.000 0.339 0.661
G93.8 Other specified disorders of brain
0.661 0.339 0.000
G30 Alzheimer's disease
0.657 0.343 0.000
G99 Other disorders of nervous system in diseases classified elsewhere
0.657 0.343 0.000
G31.8 Other specified degenerative diseases of nervous system
0.655 0.344 0.000
M06.98 Rheumatoid arthritis, unspecified (Other)
0.000 0.345 0.655
I15.1 Hypertension secondary to other renal disorders
0.000 0.345 0.655
I25.4 Coronary artery aneurysm
0.000 0.348 0.652
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.350 0.650
E85 Amyloidosis
0.002 0.350 0.648
E06.3 Autoimmune thyroiditis
0.000 0.351 0.649
G92 Toxic encephalopathy
0.648 0.352 0.000
I00-I02 Acute rheumatic fever
0.000 0.352 0.648
G00.9 Bacterial meningitis, unspecified
0.646 0.354 0.000
E07.9 Disorder of thyroid, unspecified
0.000 0.358 0.642
I25.9 Chronic ischaemic heart disease, unspecified
0.000 0.359 0.641
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.000 0.360 0.640
G93.9 Disorder of brain, unspecified
0.639 0.360 0.000
E07.8 Other specified disorders of thyroid
0.000 0.361 0.639
G08 Intracranial and intraspinal phlebitis and thrombophlebitis
0.638 0.362 0.000
E14.4 With neurological complications
0.000 0.363 0.637
G93.0 Cerebral cysts
0.636 0.364 0.000
M45-M49 Spondylopathies
0.000 0.364 0.636
I22.8 Subsequent myocardial infarction of other sites
0.000 0.365 0.635
M06.8 Other specified rheumatoid arthritis
0.000 0.365 0.634
M06.2 Rheumatoid bursitis
0.000 0.365 0.634
M06.1 Adult-onset Still's disease
0.000 0.365 0.634
E11.0 With coma
0.000 0.367 0.633
Chapter XV Pregnancy, childbirth and the puerperium
0.000 0.367 0.633
M45 Ankylosing spondylitis
0.000 0.367 0.633
J40-J47 Chronic lower respiratory diseases
0.000 0.367 0.633
O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium
0.000 0.368 0.632
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.368 0.631
O16 Unspecified maternal hypertension
0.000 0.369 0.631
M45.X9 Ankylosing spondylitis (Site unspecified)
0.000 0.372 0.628
M06.3 Rheumatoid nodule
0.000 0.372 0.628
L40.0 Psoriasis vulgaris
0.000 0.373 0.626
G91.1 Obstructive hydrocephalus
0.625 0.375 0.000
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.376 0.624
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.376 0.624
E16.4 Abnormal secretion of gastrin
0.000 0.376 0.624
E16.3 Increased secretion of glucagon
0.000 0.376 0.624
E16.1 Other hypoglycaemia
0.000 0.376 0.624
Chapter X Diseases of the respiratory system
0.000 0.379 0.621
M12 Other specific arthropathies
0.000 0.382 0.618
M09 Juvenile arthritis in diseases classified elsewhere
0.000 0.382 0.618
M08 Juvenile arthritis
0.000 0.382 0.618
G00.1 Pneumococcal meningitis
0.617 0.383 0.000
G93.6 Cerebral oedema
0.615 0.385 0.000
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system
0.612 0.388 0.000
G93.2 Benign intracranial hypertension
0.610 0.390 0.000
M06.4 Inflammatory polyarthropathy
0.000 0.390 0.610
E89.3 Postprocedural hypopituitarism
0.000 0.397 0.602
G93.7 Reye's syndrome
0.601 0.399 0.000
G40-G47 Episodic and paroxysmal disorders
0.600 0.400 0.000
G93.1 Anoxic brain damage, not elsewhere classified
0.600 0.400 0.000
E11.4 With neurological complications
0.000 0.404 0.596
E13.8 With unspecified complications
0.000 0.404 0.596
E13.7 With multiple complications
0.000 0.404 0.596
E13.6 With other specified complications
0.000 0.404 0.596
E13.5 With peripheral circulatory complications
0.000 0.404 0.596
E13.4 With neurological complications
0.000 0.404 0.596
E13.3 With ophthalmic complications
0.000 0.404 0.596
E13.2 With renal complications
0.000 0.404 0.596
E13.1 With ketoacidosis
0.000 0.404 0.596
E13.0 With coma
0.000 0.404 0.596
G03.8 Meningitis due to other specified causes
0.588 0.412 0.000
G03.2 Benign recurrent meningitis [Mollaret]
0.588 0.412 0.000
G03.1 Chronic meningitis
0.588 0.412 0.000
G03.0 Nonpyogenic meningitis
0.588 0.412 0.000
M07.6 Other enteropathic arthropathies
0.000 0.412 0.588
M07.5 Arthropathy in ulcerative colitis
0.000 0.412 0.588
M07.4 Arthropathy in Crohn's disease [regional enteritis]
0.000 0.412 0.588
M07.2 Psoriatic spondylitis
0.000 0.412 0.588
M07.1 Arthritis mutilans
0.000 0.412 0.588
M07.0 Distal interphalangeal psoriatic arthropathy
0.000 0.412 0.588
G93.5 Compression of brain
0.587 0.413 0.000
E07.1 Dyshormogenetic goitre
0.000 0.416 0.584
E07.0 Hypersecretion of calcitonin
0.000 0.416 0.584
I21.X Presumed acute myicardial infaction (unconfirmed)
0.000 0.419 0.581
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.419 0.581
E11.3 With ophthalmic complications
0.000 0.420 0.580
I21.4 Acute subendocardial myocardial infarction
0.000 0.421 0.579
G24 Dystonia
0.579 0.421 0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.425 0.575
G97.8 Other postprocedural disorders of nervous system
0.573 0.427 0.000
G11 Hereditary ataxia
0.571 0.429 0.000
E73 Lactose intolerance
0.002 0.431 0.567
G99.2 Myelopathy in diseases classified elsewhere
0.569 0.431 0.000
G80 Infantile cerebral palsy
0.569 0.431 0.000
J43 Emphysema
0.000 0.431 0.569
G83.4 Cauda equina syndrome
0.568 0.432 0.000
E83.4 Disorders of magnesium metabolism
0.564 0.433 0.004
M07.38 Other psoriatic arthropathies (Other)
0.000 0.433 0.567
M07.37 Other psoriatic arthropathies (Ankle and foot)
0.000 0.433 0.567
M07.36 Other psoriatic arthropathies (Lower leg)
0.000 0.433 0.567
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)
0.000 0.433 0.567
M07.34 Other psoriatic arthropathies (Hand)
0.000 0.433 0.567
M07.33 Other psoriatic arthropathies (Forearm)
0.000 0.433 0.567
M07.32 Other psoriatic arthropathies (Upper arm)
0.000 0.433 0.567
M07.31 Other psoriatic arthropathies (Shoulder region)
0.000 0.433 0.567
G00.8 Other bacterial meningitis
0.567 0.433 0.000
G00.3 Staphylococcal meningitis
0.567 0.433 0.000
G00.2 Streptococcal meningitis
0.567 0.433 0.000
G00.0 Haemophilus meningitis
0.567 0.433 0.000
I15.9 Seconday hypertension, unspecified
0.000 0.434 0.566
I15.8 Other secondary hypertension
0.000 0.434 0.566
I15.2 Hypertension secondary to endocrine disorders
0.000 0.434 0.566
I15.0 Renovascular hypertension
0.000 0.434 0.566
M06.09 Seronegative rheumatoid arthritis (Site unspecified)
0.000 0.437 0.563
G04.8 Other encephalitis, myelitis and encephalomyelitis
0.562 0.438 0.000
G04.2 Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified
0.562 0.438 0.000
G04.1 Tropical spastic paraplegia
0.562 0.438 0.000
G04.0 Acute disseminated encephalitis
0.562 0.438 0.000
I21.3 Acute transmural myocardial infarction of unspecified site
0.000 0.440 0.559
M05.8 Other seropositive rheumatoid arthritis
0.000 0.444 0.556
M05.3 Rheumatoid arthritis with involvement of other organs and systems
0.000 0.444 0.556
M05.2 Rheumatoid vasculitis
0.000 0.444 0.556
M05.1 Rheumatoid lung disease
0.000 0.444 0.556
M05.0 Felty's syndrome
0.000 0.444 0.556
E06.5 Other chronic thyroiditis
0.000 0.450 0.550
E06.4 Drug-induced thyroiditis
0.000 0.450 0.550
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.450 0.550
E06.1 Subacute thyroiditis
0.000 0.450 0.550
E06.0 Acute thyroiditis
0.000 0.450 0.550
G25 Other extrapyramidal and movement disorders
0.545 0.455 0.000
I11.0 Hypertensive heart disease with (congestive) heart failure
0.000 0.455 0.545
G97.1 Other reaction to spinal and lumbar puncture
0.544 0.455 0.000
G97.0 Cerebrospinal fluid leak from spinal puncture
0.542 0.457 0.000
E88 Other metabolic disorders
0.002 0.461 0.537
I21.9 Acute myocardial infarction, unspecified
0.000 0.465 0.535
O13 Gestational [pregnancy-induced] hypertension without significant proteinuria
0.000 0.466 0.534
G90 Disorders of autonomic nervous system
0.533 0.466 0.000
J45.8 Mixed asthma
0.000 0.467 0.533
J45.1 Nonallergic asthma
0.000 0.467 0.533
G83.9 Paralytic syndrome, unspecified
0.533 0.467 0.000
J85-J86 Suppurative and necrotic conditions of lower respiratory tract
0.000 0.468 0.532
G83.1 Monoplegia of lower limb
0.530 0.469 0.000
M45.X0 Ankylosing spondylitis (Multiple sites in spine)
0.000 0.472 0.528
Chapter XVI Certain conditions originating in the perinatal period
0.000 0.472 0.528
M14.6 Neuropathic arthropathy
0.000 0.472 0.528
M11.2 Other chondrocalcinosis
0.000 0.476 0.524
M10 Gout
0.000 0.476 0.524
G97.9 Postprocedural disorder of nervous system, unspecified
0.522 0.477 0.000
G97.2 Intracranial hypotension following ventricular shunting
0.522 0.477 0.000
M91-M94 Chondropathies
0.000 0.478 0.522
E05.9 Thyrotoxicosis, unspecified
0.000 0.479 0.521
G06.1 Intraspinal abscess and granuloma
0.520 0.479 0.000
E05.8 Other thyrotoxicosis
0.000 0.481 0.519
E05.5 Thyroid crisis or storm
0.000 0.481 0.519
E05.4 Thyrotoxicosis factitia
0.000 0.481 0.519
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.481 0.519
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.481 0.519
G40 Epilepsy
0.519 0.481 0.000
G96.0 Cerebrospinal fluid leak
0.518 0.481 0.000
G91.8 Other hydrocephalus
0.518 0.482 0.000
G91.3 Posttraumatic hydrocephalus, unspecified
0.518 0.482 0.000
G91.2 Normal-pressure hydrocephalus
0.518 0.482 0.000
G91.0 Communicating hydrocephalus
0.518 0.482 0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities
0.000 0.484 0.515
J43.9 Emphysema, unspecified
0.000 0.485 0.515
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
G36.9 Acute disseminated demyelination, unspecified
0.513 0.486 0.000
G36.8 Other specified acute disseminated demyelination
0.513 0.486 0.000
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]
0.513 0.486 0.000
G36.0 Neuromyelitis optica [Devic]
0.513 0.486 0.000
G81 Hemiplegia
0.513 0.487 0.000
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)
0.000 0.488 0.512
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)
0.000 0.488 0.512
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)
0.000 0.488 0.512
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.488 0.512
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)
0.000 0.488 0.512
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)
0.000 0.488 0.512
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)
0.000 0.488 0.512
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.488 0.512
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction
0.000 0.489 0.510
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction
0.000 0.489 0.510
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction
0.000 0.489 0.510
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction
0.000 0.489 0.510
I23.2 Ventricular septal defect as current complication following acute myocardial infarction
0.000 0.489 0.510
I23.1 Atrial septal defect as current complication following acute myocardial infarction
0.000 0.489 0.510
I23.0 Haemopericardium as current complication following acute myocardial infarction
0.000 0.489 0.510
O94-O99 Other obstetric conditions, not elsewhere classified
0.000 0.492 0.508
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.001 0.493 0.506
E70.8 Other disorders of aromatic amino-acid metabolism
0.001 0.493 0.506
E70.3 Albinism
0.001 0.493 0.506
E70.2 Disorders of tyrosine metabolism
0.001 0.493 0.506
E70.1 Other hyperphenylalaninaemias
0.001 0.493 0.506
E70.0 Classical phenylketonuria
0.001 0.493 0.506
E71.3 Disorders of fatty-acid metabolism
0.001 0.493 0.506
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.001 0.493 0.506
E71.1 Other disorders of branched-chain amino-acid metabolism
0.001 0.493 0.506
E71.0 Maple-syrup-urine disease
0.001 0.493 0.506
E72.9 Disorder of amino-acid metabolism, unspecified
0.001 0.493 0.506
E72.8 Other specified disorders of amino-acid metabolism
0.001 0.493 0.506
E72.5 Disorders of glycine metabolism
0.001 0.493 0.506
E72.4 Disorders of ornithine metabolism
0.001 0.493 0.506
E72.3 Disorders of lysine and hydroxylysine metabolism
0.001 0.493 0.506
E72.2 Disorders of urea cycle metabolism
0.001 0.493 0.506
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.001 0.493 0.506
E72.0 Disorders of amino-acid transport
0.001 0.493 0.506
E74.9 Disorder of carbohydrate metabolism, unspecified
0.001 0.493 0.506
E74.8 Other specified disorders of carbohydrate metabolism
0.001 0.493 0.506
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.001 0.493 0.506
E74.3 Other disorders of intestinal carbohydrate absorption
0.001 0.493 0.506
E74.2 Disorders of galactose metabolism
0.001 0.493 0.506
E74.1 Disorders of fructose metabolism
0.001 0.493 0.506
E74.0 Glycogen storage disease
0.001 0.493 0.506
E75.6 Lipid storage disorder, unspecified
0.001 0.493 0.506
E75.5 Other lipid storage disorders
0.001 0.493 0.506
E75.4 Neuronal ceroid lipofuscinosis
0.001 0.493 0.506
E75.3 Sphingolipidosis, unspecified
0.001 0.493 0.506
E75.2 Other sphingolipidosis
0.001 0.493 0.506
E75.1 Other gangliosidosis
0.001 0.493 0.506
E75.0 GM2 gangliosidosis
0.001 0.493 0.506
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.001 0.493 0.506
E76.8 Other disorders of glucosaminoglycan metabolism
0.001 0.493 0.506
E76.3 Mucopolysaccharidosis, unspecified
0.001 0.493 0.506
E76.2 Other mucopolysaccharidoses
0.001 0.493 0.506
E76.1 Mucopolysaccharidosis, type II
0.001 0.493 0.506
E76.0 Mucopolysaccharidosis, type I
0.001 0.493 0.506
E77.9 Disorder of glycoprotein metabolism, unspecified
0.001 0.493 0.506
E77.8 Other disorders of glycoprotein metabolism
0.001 0.493 0.506
E77.1 Defects in glycoprotein degradation
0.001 0.493 0.506
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.001 0.493 0.506
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.001 0.493 0.506
E79.8 Other disorders of purine and pyrimidine metabolism
0.001 0.493 0.506
E79.1 Lesch-Nyhan syndrome
0.001 0.493 0.506
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.001 0.493 0.506
E84.9 Cystic fibrosis, unspecified
0.001 0.493 0.506
E84.8 Cystic fibrosis with other manifestations
0.001 0.493 0.506
E84.1 Cystic fibrosis with intestinal manifestations
0.001 0.493 0.506
E84.0 Cystic fibrosis with pulmonary manifestations
0.001 0.493 0.506
J42 Unspecified chronic bronchitis
0.000 0.493 0.507
I23.8 Other current complications following acute myocardial infarction
0.000 0.494 0.506
G44 Other headache syndromes
0.504 0.496 0.000
G13 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere
0.503 0.497 0.000
G14 Postpolio syndrome
0.503 0.497 0.000
G10 Huntington's disease
0.503 0.497 0.000
I13.9 Hypertensive heart and renal disease, unspecified
0.000 0.497 0.502
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure
0.000 0.497 0.502
I13.1 Hypertensive heart and renal disease with renal failure
0.000 0.497 0.502
I13.0 Hypertensive heart and renal disease with (congestive) heart failure
0.000 0.497 0.502
G30.0 Alzheimer's disease with early onset
0.502 0.498 0.000
M06.08 Seronegative rheumatoid arthritis (Other)
0.000 0.501 0.499
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)
0.000 0.501 0.499
M06.06 Seronegative rheumatoid arthritis (Lower leg)
0.000 0.501 0.499
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)
0.000 0.501 0.499
M06.04 Seronegative rheumatoid arthritis (Hand)
0.000 0.501 0.499
M06.03 Seronegative rheumatoid arthritis (Forearm)
0.000 0.501 0.499
M06.02 Seronegative rheumatoid arthritis (Upper arm)
0.000 0.501 0.499
M06.01 Seronegative rheumatoid arthritis (Shoulder region)
0.000 0.501 0.499
K90 Intestinal malabsorption
0.000 0.502 0.498
G06.2 Extradural and subdural abscess, unspecified
0.498 0.502 0.000
G82 Paraplegia and tetraplegia
0.498 0.502 0.000
G94.1 Hydrocephalus in neoplastic disease
0.497 0.503 0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)
0.000 0.505 0.495
G72 Other myopathies
0.494 0.506 0.000
L41.9 Parapsoriasis, unspecified
0.000 0.508 0.492
L41.8 Other parapsoriasis
0.000 0.508 0.492
L41.5 Retiform parapsoriasis
0.000 0.508 0.492
L41.4 Large plaque parapsoriasis
0.000 0.508 0.492
L41.3 Small plaque parapsoriasis
0.000 0.508 0.492
L41.2 Lymphomatoid papulosis
0.000 0.508 0.492
L41.1 Pityriasis lichenoides chronica
0.000 0.508 0.492
L41.0 Pityriasis lichenoides et varioliformis acuta
0.000 0.508 0.492
L44.9 Papulosquamous disorder, unspecified
0.000 0.508 0.492
L44.8 Other specified papulosquamous disorders
0.000 0.508 0.492
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.000 0.508 0.492

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.